Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-07-01
1996-04-16
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514533, 514544, 514545, 514570, 514571, 562459, A61K 3119, A61K 31235, A61K 31215
Patent
active
055083099
ABSTRACT:
This invention relates to a compound of the formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein X is oxygen, sulfur, --CH.dbd.CH--, or --CH.dbd.N--;
REFERENCES:
patent: 3255241 (1966-06-01), Schultz et al.
patent: 3912656 (1975-10-01), Andrews et al.
patent: 3919250 (1975-11-01), Pauling et al.
patent: 4015010 (1977-03-01), Houlihan et al.
patent: 4381360 (1983-04-01), Leistner et al.
patent: 4469885 (1984-09-01), Mueller et al.
Fackler, Progress Inorg. Chem., "Metal .beta.-Ketoenolate Complexes" pp. 361-425 (1966).
Singh, et al., Progress in Medicinal Chem., vol. 17, Elseveer, Chap. 4-Medicinal Chem. of Tetrazoles, pp. 151-183 (1980).
Thornber, Chem. Society Reviews, vol. 8, pp. 563-580 (1979).
Djuric Stevan W.
Haack Richard A.
Miyashiro Julie M.
Dentz Bernard
Feder Scott B.
G. D. Searle & Co.
Williams Roger A.
LandOfFree
LTB4 synthesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with LTB4 synthesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LTB4 synthesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325520